Ask AI
ProCE Banner Activity

CE / CME

The Next Frontier: Rapid AST to Optimize Care of Patients With Bloodstream Infections

Video

Learn more about the capabilities of rapid phenotypic AST platforms to improve patient outcomes and antimicrobial stewardship, and gain strategies for the timely determination of antibiotic susceptibility in Gram-negative organisms among patients with sepsis.

Pharmacists: 1.25 contact hours (0.125 CEUs)

Nurse Practitioners/Nurses: 1.25 Nursing contact hours

Physicians: maximum of 1.25 AMA PRA Category 1 Credits

Released: November 06, 2025

Expiration: November 05, 2026

Share

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC

ProCE Banner

Supporters

Supported by an educational grant from bioMérieux.

bioMérieux

Partners

ProCE

ProCE Banner

Target Audience

This activity is intended for ID specialists, including physicians, pharmacists, nurse practitioners, and other HCPs who provide care for patients with BSIs. 

Program Learning Goal

The goal of this activity is to improve the knowledge and competence of learners regarding the optimal use of rapid phenotypic AST for the management of patients with BSIs.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the potential benefits of rapid phenotypic AST for patients with Gram-negative BSIs

  • Utilize rapid genotypic and phenotypic AST results to inform antibiotic selection for patients with Gram-negative BSIs

  • Formulate strategies for optimal integration of rapid phenotypic AST into clinical practice, including incorporation into antimicrobial stewardship workflow

Disclosure

Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Jose Alexander, MD, D(ABMM), CIC, FCCM, SM/MB(ASCP): consultant/advisor/speaker: AbbVie, BioMerieux, Cepheid, Melinta, Merck, Shionogi.

Jasmine R. Marcelin, MD, FACP, FIDSA, has no relevant financial relationships to disclose.

Michael P. Veve, PharmD, MPH: consultant/advisor/speaker: BioMerieux Inc, Merck Sharp & Dohme; researcher: Innoviva Therapeutics. 

The planners and content peer reviewers from Clinical Care Options, LLC and ProCE, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.25 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 06, 2025, through November 05, 2026:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.25 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.25 contact hours (0.125 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: xxxx

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.